ACRS vs REGN: Which Stock is Better?
Side-by-side comparison of Aclaris Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
ACRS
Aclaris Therapeutics Inc
$4.43
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | ACRS | REGN | Winner |
|---|---|---|---|
| Market Cap | $283.86M | $77.69B | REGN |
| P/E Ratio | N/A | 17.57 | REGN |
| EPS (TTM) | $N/A | $41.71 | REGN |
| Revenue Growth | -0.2% | 0.0% | REGN |
| Gross Margin | -275.7% | 45.8% | REGN |
Analyze ACRS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRS or REGN a better investment?
Comparing ACRS and REGN: Aclaris Therapeutics Inc has a market cap of $283.86M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRS and REGN?
ACRS (Aclaris Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRS or REGN?
REGN has higher revenue growth at 0.0% vs -0.2% for ACRS.
Which company is more profitable: ACRS or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to -275.7% for ACRS.
Which is the larger company: ACRS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $283.86M for ACRS.
Should I buy ACRS or REGN in 2026?
Both ACRS and REGN have investment merit. ACRS trades at $4.43 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRS and REGN stock?
Key differences: Market Cap ($283.86M vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-0.2% vs 0.0%), Gross Margin (-275.7% vs 45.8%).